Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 1, 1998, Pages 106-116

  Flynn, Michael A ^a   Haleen, Stephen J ^a   Welch, Kathleen M ^a   Cheng, Xue Min ^a   Reynolds, Elwood E ^a  

^a PFIZER INC   (United States)

Author keywords

Endothelial cells; Endothelin; Endothelin antagonists; Endothelin receptors; Receptor subtypes; Smooth muscle cells

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; RECEPTOR SUBTYPE; SARAFOTOXIN S6C;

ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

BINDING, COMPETITIVE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; MUSCLE, SMOOTH, VASCULAR; OLIGOPEPTIDES; PEPTIDES, CYCLIC; RADIOLIGAND ASSAY; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; SULFONAMIDES;

EID: 0031799003     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199807000-00017     Document Type: Article

References (53)

1. Yanagasawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Masaki T, Kimura S, Yangasawa M, Goto K. Molecular and cellular mechanism of endothelin regulation. Circulation 1991;84: 1457-68.
3. Simonson MS, Herman WH. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. J Biol Chem 1993;268:9347-57.
4. Arai K, Hori S, Aromori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
5. Sakurai T, Yanagasawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-5.
6. Warner TD, Allcock GK, Corder R, Vane JR. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 1993;110:777-82.
7. Warner TD, Allcock GH, Mickley EJ, Corder R, Vane JR. Comparative studies with the endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors. J Cardiovasc Pharmacol 1993;22 Suppl 8:S117-20.
8. Clozel M, Breu V, Gray GA, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270:228-34.
9. B-receptors in the human saphenous vein. Jpn J Pharmacol 1995;69:391-8.
10. Miasiro N, Karaki H, Paiva ACM. Heterogeneous endothelin receptors mediate relaxation and contraction in the guinea pig ileum. Eur J Pharmacol 1995;285(3):247-54.
11. Gellai M, Fletcher T, Pullen M, Nambi P. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol 1996;271:R254-61.
12. Nishiyama M, Moroi K, Shan L, et al. Two different endothelin B receptor subtypes mediate contraction of the rabbit saphenous vein. Jpn J Pharmacol 1995;68(3):235-43.
13. Douglas SA, Beck GR, Elliott JD, Ohlstem EH. Pharmacologic evidence for the presence of three functional endothelin receptor subtypes in rabbit saphenous vein. J Cardiovasc Pharmacol 1995;26 Suppl 3:S163-8.
14. Hall JM, Caulfield MP, Watson SP, Guard S. Receptor subtypes or species homologues: relevance to drug discovery. Trends Pharmacol Sci 1993;14:376-83.
15. Bax WA, Saxena PR. The current endothelin receptor classification: time for reconsideration? Trends Pharmacol Sci 1994;15:379-86.
16. Kumar C, Mwangi V, Nuthulaganti P, et al. Cloning and characterization of a novel endothelin receptor from Xenopus heart. J Biol Chem 1994;269:13414-20.
17. Battistini B, Germain M, Fournier A, Sirois P. Structure-activity relationships of ET-1 and selected analogues in the isolated guinea pig trachea: evidence for the existence of different ETB receptor subtypes. J Cardiovasc Pharmacol 1993;22 Suppl 8:S219-24.
18. B receptors in human vascular smooth muscle. J Cardiovasc Pharmacol 1993;22 Suppl 8:S22-5.
19. C receptor) from Xenopus laevis dermal melanophores. J Biol Chem 1993;268:19126-33.
20. Reynolds EE, Hwang O, Flynn MA, et al. Pharmacological differences between rat and human endothelin B receptors. Biochem Biophys Res Commun 1995;209:506-12.
21. Fukuroda T, Kobayashi M, Ozaki S, et al. Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol 1994;76:1976-82.
22. 125I]IRL-1620, a potent agonist specific for endothelin-B receptors. J Pharmacol Ther 1994;268:202-7.
23. Milner P, Bodin P, Loesch A, Burnstock G. Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun 1990;170:649-56.
24. Corder R, Harrison VJ, Khan N, Anggard EE, Vane JR. Effects of phosphoramidon in endothelial cell cultures on the endogenous synthesis of endothelin-1 and on the conversion of exogenous big endothelin-1 to endothelin-1. J Cardiovasc Pharmacol 1993;22 Suppl 8:573-6.
25. Resink TJ, Hahn AWA, Scott-Burden T, Powell J, Weber E, Buhler FR. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun 1990;168:1303-10.
26. Clozel M, Loftier B-M, Breu V, Hilfiger L, Maire JP, Butsha B. Downregulation of endothelin receptors by autocrine production of endothelin-1. Am J Physiol 1993;265:C188-92.
27. Wu-Wong JR, Chiou WJ, Opgenorth TJ. Prolonged treatment by phosphoramidon modulates the number of endothelin receptors in cultured Swiss 3T3 fibroblasts. J Cardiovasc Pharmacol 1993;22 Suppl 8:577-80.
28. Fujitani Y, Oda K, Takimoto M, Inui T, Okada T, Urade Y. Autocrine receptors for endothelins in the primary culture of endothelial cells of human umbilical vein. FEBS Lett 1992;298:79-83.
29. Lapone J, D'Orleans-Juste P, Singh G, Sirois P. Dexamethasone and phosphoramidon inhibit endothelin release by cultured nonciliated bronchiolar epithelial (Clara) cells. J Cardiovasc Pharmacol 1995;26 Suppl 3:553-5.
30. Yazawa H, lida-Kubota E, Honma Y, Honda K. Characterization of the endothelin receptor in primary cultures of human aortic smooth muscle cells. Jpn J Pharmacol 1993;63:313-8.
31. Cody WL, Doherty AM, He JX, et al. Design of a functional antagonist of endothelin. J Med Chem 1992;35:3301-3.
32. Ishikawa K, Ihara M, Noguchi K, et al. Biochemical and pharmacological profile of a potent and selective endothelin B receptor antagonist, BQ-788. Proc Natl Acad Sci U S A 1994;91:4892-6.
33. B receptors. J Pharmacol Exp Ther 1994b;271:755-61.
34. Ohlstein EH, Beck GR, Douglas SA, et al. Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. J Pharmacol Exp Ther 1994;271:762-8.
35. Webb ML, Chao C, Rizzo M, et al. Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contraction. Mol Pharmacol 1995;47:730-7.
36. Tsukahara K, Ende H, Magazine HI, Bahou WF, Goligorsky MS. Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. J Biol Chem 1994;269: 21778-85.
37. Mizuguchi T, Nishiyama M, Moroi K, et al. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Br J Pharmacol 1997;120: 1427-30.
38. Webb ML, Liu EC, Moshizadegan H. Expression of endothelin receptor subtypes in rabbit saphenous vein. Mol Pharmacol 1993;44: 959-65.
39. Elshourbagy N, Korman D, Nuthulaganti P, et al. Molecular characterization and regulation of the human endothelin receptors. J Biol Chem 1993;268:3873-9.
40. Mauzy C, Wu L-H Egloff AM, Mirzadegan T, Chung F-Z. Substitution of lysine-181 to aspartic acid in the third transmembrane region of the endothelin (ET) type B receptor selectively reduces its high-affinity binding with ET-3 peptide. J Cardiovasc Pharmacol 1992;20 Suppl 12:S5-7.
41. Krystek SR, Patel PS, Rose PM, et al. Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. J Biol Chem 1994;269:12383-6.
42. Cheng H-F, Su Y-M, Yeh J-R, Chang K-J. Alternative transcript of the nonselective-type endothelin receptor from rat brain. Mol Pharmacol 1993;44:533-8.
43. Shyamala V, Moulthrop, THM, Stratton-Thomas J, Tekamp-Olson P. Two distinct human endothelin B receptors generated by alternative splicing from a single gene. Cell Mol Biol Res 1994;40: 285-96.
44. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992;186:867-73.
45. B receptors mediating constriction and relaxation? J Cardiovasc Pharmacol 1995;26 Suppl 3:S262-4.
46. B selective ligands in human and rat heart. Br J Pharmacol 1996;119(4):631-6.
47. Sachais BS, Snider RM, Lowe JA III, Krause JE. Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J Biol Chem 1993;268:2319-3.
48. Beinborn M, Lee Y-M, McBride EW, Quinn SM, Kopin AS. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature 1993; 362:348-50.
49. Simonson M, Dunn M. Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates α-adrenergic mediated cyclic adenosine monophosphate accumulation. J Clin Invest 1990;85: 790-7.
50. Warner TD, deNucci G, Vane JR. Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 1989;159:325-6.
51. B) receptors in rabbit isolated pulmonary artery and bronchus. Br J Pharmacol 1996;188(5):1209-17.
52. Hiley CR, McStay MKG, Bottrill FE, Douglas SA. Cross-desensitization studies with endothelin isopeptides in the rat isolated superior mesenteric arterial bed. J Vasc Res 1992;92:135-40.
53. 50) of an enzymatic reaction. Biochem Pharmacol 1973; 22:3099-108.